Monday - Friday - 8:00 - 16:30   |   Weekends - Closed

The Aurum Institute

A proudly African, public-benefit organisation with over 18 years’ experience in leading the response, treatment and research efforts to eradicate TB and HIV.

Dr Elizabeth Corbett

  • Title:: Professor of Tropical Epidemiology
  • Qualifications:: BA, MB, BChir, FRCP, PhD
  • Location:: London

Elizabeth Corbett is a Welcome Trust Senior Fellow and a Clinical Epidemiologist with the London School of Hygiene and Tropical Medicine, based full time in Blantyre, Malawi. Her main research interests concern control of TB in HIV prevalent populations and HIV epidemiology with a focus on adolescent long-term survivors of perinatal HIV transmission.Ellner is internationally recognised for his research on tuberculosis and its interactions with HIV infection. He has published more than 250 original articles in the peer-reviewed scientific literature. He was the principal architect of the Uganda-Case Western Reserve University Research Collaboration, which was extended to UNMNJ and is a founding member of the Academic Alliance for AIDS Care and Prevention in Africa.

Elizabeth’s primary focus is on public health interventions at primary care and community level, including both cluster-randomized trials and alternative non-randomized impact evaluation designs. She has a long-standing interest in respiratory complications of HIV, following research on TB, non-tuberculous mycobacterial disease and fibrotic lung disease in South African miners in the 1990s.

Elizabeth’s previous research has highlighted the public health importance of undiagnosed infectious TB and community-level interventions providing access to TB and HIV diagnosis, with her leadership in this field recognised by membership on a number of Advisory and Working Groups for the HIV and Global TB Programs of the World Health Organization. She has a current major focus on the evaluation of the health benefits of oral self-testing for HIV, using similar approaches to those proposed in the current proposal, as well as ongoing facility-based trials in investigating the response to novel treatment of adolescent perinatal HIV infection, and the impact of new TB diagnostics.